Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Goetz

Showing results (21-30 of 265) with videos related to

Pageof 27
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
CYP2D6 and tamoxifen: awaiting the denouementHiltrud B Brauch, Werner Schroth, James N Ingle, et al.
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|October 4, 2005
Clinical trial designs for prospective validation of biomarkersSumithra J Mandrekar, Axel Grothey, Matthew P Goetz, et al.
Cancers|July 12, 2025
Anti-Neoplastic Activity of Estrogen Receptor Beta in Chemoresistant Triple-Negative Breast CancerXiyin Wang, Michael J Emch, Matthew P Goetz, et al.
Endocrinology|September 4, 2021
Endoxifen, an Estrogen Receptor Targeted Therapy: From Bench to BedsideSwaathi Jayaraman, Joel M Reid, John R Hawse, et al.
Oncology (Williston Park, N.Y.)|March 28, 2009
Endocrine therapy in 2009: consideration of the tumor and the hostMatthew P Goetz, Matthew M Ames, M Weinshilboum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2024
Revisiting Combined Modality Therapy in Older Patients With Luminal Breast Cancer Through the Patient LensRobert W Mutter, Cynthia Chauhan, Matthew P Goetz, et al.
Annals of Surgical Oncology|July 25, 2022
Nodal Pathologic Complete Response Rates in Luminal Breast Cancer Vary by Genomic RiskJudy C Boughey, Tanya L Hoskin, Courtney N Day, et al.
Cancer Chemotherapy and Pharmacology|December 17, 2009
Synergistic interactions between aminoflavone, paclitaxel and camptothecin in human breast cancer cellsKathryn E Reinicke, Mary J Kuffel, Matthew P Goetz, et al.
The Lancet. Oncology|April 24, 2010
Clinical implementation of pharmacogenomics: overcoming genetic exceptionalismMary V Relling, Russ B Altman, Matthew P Goetz, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Innovative Strategies: Targeting Subtypes in Metastatic Breast CancerMark D Pegram, Yu Zong, Clinton Yam, et al.
Pageof 27

Showing results (21-30 of 265) with videos related to

Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
CYP2D6 and tamoxifen: awaiting the denouementHiltrud B Brauch, Werner Schroth, James N Ingle, et al.
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|October 4, 2005
Clinical trial designs for prospective validation of biomarkersSumithra J Mandrekar, Axel Grothey, Matthew P Goetz, et al.
Cancers|July 12, 2025
Anti-Neoplastic Activity of Estrogen Receptor Beta in Chemoresistant Triple-Negative Breast CancerXiyin Wang, Michael J Emch, Matthew P Goetz, et al.
Endocrinology|September 4, 2021
Endoxifen, an Estrogen Receptor Targeted Therapy: From Bench to BedsideSwaathi Jayaraman, Joel M Reid, John R Hawse, et al.
Oncology (Williston Park, N.Y.)|March 28, 2009
Endocrine therapy in 2009: consideration of the tumor and the hostMatthew P Goetz, Matthew M Ames, M Weinshilboum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2024
Revisiting Combined Modality Therapy in Older Patients With Luminal Breast Cancer Through the Patient LensRobert W Mutter, Cynthia Chauhan, Matthew P Goetz, et al.
Annals of Surgical Oncology|July 25, 2022
Nodal Pathologic Complete Response Rates in Luminal Breast Cancer Vary by Genomic RiskJudy C Boughey, Tanya L Hoskin, Courtney N Day, et al.
Cancer Chemotherapy and Pharmacology|December 17, 2009
Synergistic interactions between aminoflavone, paclitaxel and camptothecin in human breast cancer cellsKathryn E Reinicke, Mary J Kuffel, Matthew P Goetz, et al.
The Lancet. Oncology|April 24, 2010
Clinical implementation of pharmacogenomics: overcoming genetic exceptionalismMary V Relling, Russ B Altman, Matthew P Goetz, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Innovative Strategies: Targeting Subtypes in Metastatic Breast CancerMark D Pegram, Yu Zong, Clinton Yam, et al.
Pageof 27